Biomedical Engineering Reference
In-Depth Information
67. Nury H, Poitevin F, Van Renterghem C, Changeux JP, Corringer PJ, Delarue M, Baaden M
(2010) One-microsecond molecular dynamics simulation of channel gating in a nicotinic
receptor homologue. Proc Natl Acad Sci USA 107:6275-6280
68. Brejc K, Van Dijk WJ, Klaassen RV, Schuurmans M, Van Der Oost J, Smit AB, Sixma TK
(2001) Crystal structure of an ACh-binding protein reveals the ligand-binding domain of
nicotinic receptors. Nature 411:269-276
69. Bourne Y, Radic Z, Ar´oz R, Talley TT, Benoit E, Servent D, Taylor P, Molg´ J, Marchot P
(2010) Structural determinants in phycotoxins and AChBP conferring high affinity binding
and nicotinic AChR antagonism. Proc Natl Acad Sci USA 107:6076-6081
70. Gonzales EB, Kawate T, Gouaux E (2009) Pore architecture and ion sites in acid-sensing ion
channels and P2X receptors. Nature 460:599-604
71. Jiang Y, Lee A, Chen J, Ruta V, Cadene M, Chait BT, MacKinnon R (2003) X-ray structure
of a voltage-dependent K+ channel. Nature 423:33-41
72. Kim ST, Weaver DF (2000) Theoretical studies on Alzheimer's disease: structures of beta-
amyloid aggregates. J Mol Struct - Theochem 527:127-138
73. Cordes FS, Kukol A, Forrest LR, Arkin IT, SansomMSP, Fischer WB (2001) The structure of
the HIV-1 Vpu ion channel: modelling and simulation studies. Biochim Biophys Acta
Biomembr 1512:291-298
74. Hardman RM, Stansfeld PJ, Dalibalta S, Sutcliffe MJ, Mitcheson JS (2007) Activation gating
of hERG potassium channels: S6 glycines are not required as gating hinges. J Biol Chem
282:31972-31981
75. Pietraa F (2008) Binding of ciguatera toxins to the voltage-gated Kv1.5 potassium channel in
the open state. Docking of gambierol and molecular dynamics simulations of a homology
model. J Phys Org Chem 21:997-1001
76. Fu W, Cui M, Briggs JM, Huang X, Xiong B, Zhang Y, Luo X, Shen J, Ji R, Jiang H, Chen K
(2002) Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin
with the voltage-gated potassium ion channels. Biophys J 83:2370-2385
77. Cheng X, Ivanov I, Wang H, Sine SM, McCammon JA (2007) Nanosecond-timescale confor-
mational dynamics of the human
7 nicotinic acetylcholine receptor. Biophys J 93:2622-2634
78. Speranskiy K, Cascio M, Kurnikova M (2007) Homology modeling and molecular dynamics
simulations of the glycine receptor ligand binding domain. Proteins 67:950-960
79. Ekins S, Crumb WJ, Sarazan RD, Wikel JH, Wrighton SA (2002) Three-dimensional
quantitative structure-activity relationship for inhibition of human ether-a-go-go-related
gene potassium channel. J Pharmacol Exp Ther 301:427-434
80. Pearlstein RA, Vaz RJ, Kang J, Chen X-L, Preobrazhenskaya M, Shchekotikhin AE, Korolev
AM, Lysenkova LN, Miroshnikova OV, Hendrix J, Rampe D (2003) Characterization of
HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling
approaches. Bioorg Med Chem Lett 13:1829-1835
81. Aronov AM, Goldman BB (2004) A model for identifying HERG K+ channel blockers.
Bioorg Med Chem 12:2307-2315
82. Aronov AM (2005) Predictive in silico modeling for hERG channel blockers. Drug Discov
Today 10:149-155
83. Cianchetta G, Li Y, Kang J, Rampe D, Fravolini A, Cruciani G, Vaz RJ (2005) Predictive
models for hERG potassium channel blockers. Bioorg Med Chem Lett 15:3637-3642
84. Recanatini M, Poluzzi E, Masetti M, Cavalli A, Ponti FD (2005) QT prolongation through
hERG K+ channel blockade: current knowledge and strategies for the early prediction during
drug development. Med Res Rev 25:133-166
85. Diller DJ, Hobbs DW (2007) Understanding hERG inhibition with QSAR models based on a
one-dimensional molecular representation. J Comput Aided Mol Des 21:379-393
86. Kramer C, Beck B, Kriegl JM, Clark T (2008) A composite model for hERG blockade.
ChemMedChem 3:254-265
87. Thai K-M, Ecker GF (2008) A binary QSAR model for classification of hERG potassium
channel blockers. Bioorg Med Chem 16:4107-4119
a
